Mareike Roth
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Cancer Research top 10%
Papers in
-
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Retinoids in leukemia and cellular processes 2
- Epigenetics and DNA Methylation 1
-
- Acute Myeloid Leukemia Research 8
- Co-authors
- Johannes Zuber (13 shared papers)Inês Amorim Monteiro Barbosa (2 shared papers)Matthias Muhar (2 shared papers)Christof Fellmann (1 shared paper)Thomas Hoffmann (3 shared papers)Barbara Hopfgartner (1 shared paper)Markus Jaritz (2 shared papers)Meinrad Busslinger (2 shared papers)
- Journals
- The EMBO Journal (1 paper)Oncogene (1 paper)Blood (1 paper)Frontiers in Neuroscience (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Mareike Roth
17 papers receiving 934 citations
Peers
Comparison fields: 5 of 71
- Hematology 188
- Cancer Research 156
- Molecular Biology 625
- Immunology 147
- Oncology 139
Countries citing papers authored by Mareike Roth
This map shows the geographic impact of Mareike Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mareike Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mareike Roth more than expected).
Fields of papers citing papers by Mareike Roth
This network shows the impact of papers produced by Mareike Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mareike Roth. The network helps show where Mareike Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mareike Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 455 | |
| 2 | 2014 | 166 | |
| 3 | 2017 | 60 | |
| 4 | 2015 | 51 | |
| 5 | 2015 | 48 | |
| 6 | 2018 | 44 | |
| 7 | 2017 | 32 | |
| 8 | 1994 | 32 | |
| 9 | 2013 | 20 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 7 | |
| 12 | 2016 | 5 | |
| 13 | 2022 | 2 | |
| 14 | 2014 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2014 | 0 | |
| 19 | 2017 | 0 |
About Mareike Roth
Mareike Roth is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Social Psychology and Genetics, having authored 19 papers that have together received 943 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Psychology, Coaching, and Therapy (2 papers), Ubiquitin and proteasome pathways (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Hematology (188 citations), Cancer Research (156 citations), Molecular Biology (625 citations), Immunology (147 citations) and Oncology (139 citations). Mareike Roth has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Johannes Zuber, Inês Amorim Monteiro Barbosa, Matthias Muhar, Christof Fellmann, Thomas Hoffmann, Barbara Hopfgartner, Markus Jaritz, Meinrad Busslinger, Barbara Werner and Martina Minnich. Their work appears in journals such as The EMBO Journal, Oncogene, Blood, Frontiers in Neuroscience and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.